Here are nine new drug shortages to know, according to databases compiled by the FDA and the American Society of Health-System Pharmacists.
Category: Static
Cleveland Clinic CEO: The future of AI and quantum computing in healthcare
Cleveland Clinic is on the forefront of digital transformation and AI integration into healthcare. What’s next for the system?
FDA lifts clinical hold on combined COVID-19-influenza vaccine trials
Novavax received clearance from the FDA to move forward with phase 3 clinical trials for its COVID-19-influenza combination (CIC) and standalone influenza vaccines.
GLP-1, SGLT2s lower mortality risk by 74% in stroke survivors: Study
Stroke survivors who took GLP-1 or SGLT2 medications had a 74% lower risk of death, according to a preliminary study being presented at the American Heart Association’s annual Scientific Sessions, set for Nov. 16-18.
Hypertension in the US: 5 notes
Nearly half of all adults in the U.S. had hypertension between August 2021 and 2023, though men were less likely to be aware of their status.
Hippocratic AI forms visionary advisor board
Hippocratic AI, the pioneering company behind the first safety-focused large language model for healthcare, is set to reshape the healthcare landscape with the guidance of its newly established Healthcare Advisory Board.
AMA aims to cut retrospective denials: 4 things to know
The American Medical Association is pushing for tighter protections over prior authorization requirements due to continued physician frustration.
West Virginia school researches nanotechnology to prevent drug-resistant infections
Researchers at Morgantown-based West Virginia University are working to reduce antibiotic-resistant infections in open bone fractures by using nanotechnology.
The cybersecurity risk of healthcare AI: 6 things to know
With the rise in artificial intelligence use, healthcare organizations block more AI activity than most other industries.
Indiana system sues Humana over withheld reimbursements
Indianapolis-based Community Health Network is suing Humana for allegedly failing to reimburse it for 340B drugs provided to the payer’s members, the Indianapolis Business Journal reported Nov. 11.
